Zivo Bioscience

Zivo Bioscience EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Zivo Bioscience (ZIVO) as of Oct 21, 2026 is -12.30. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -8.94 — a change of 37.56% (lower).

EV/FCF

-12.30

YoY

37.56%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Zivo Bioscience is 2025 -12.30 . EV/FCF (Enterprise Value to Free Cash Flow) of Zivo Bioscience was 2024 -8.94 . It decreases by 37.56% lower compared to the previous year.

The Zivo Bioscience EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-11.51 USD
Jan 1, 2019
-12.08 USD
Jan 1, 2020
-17.42 USD
Jan 1, 2021
-4.59 USD
Jan 1, 2022
-5.42 USD
Jan 1, 2023
-6.88 USD
Jan 1, 2024
-8.94 USD
Jan 1, 2025
-12.30 USD
The Zivo Bioscience EV/FCF history
YEAREV/FCFYoY
-12.30+37.56%
-8.94+29.88%
-6.88+27.00%
-5.42+18.17%
-4.59-73.66%
-17.42+44.13%
-12.08+4.98%
-11.51-14.89%
-13.52-30.74%
-19.53-2.51%
-20.03+24.93%
-16.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zivo Bioscience Stock analysis

What does Zivo Bioscience do? Zivo Bioscience, Inc. generates revenue by developing and selling natural bioactive ingredients derived from its proprietary algal strains to manufacturers in the animal, human, dietary supplement, and medical food industries. The company focuses on research and identification of bioactive molecules for use in products targeting autoimmune and inflammatory response modulation. It also develops and sells health optimization tests that help users identify future health risks and personalize their wellness approaches. The firm manufactures algal products and derivatives through its proprietary platforms, serving both human and animal health markets. The company's primary customers include manufacturers of dietary supplements, medical foods, and pharmaceuticals seeking natural ingredients for their formulations. These manufacturers utilize Zivo's bioactive molecules to create products that address autoimmune and inflammatory conditions. Additionally, the company's health optimization tests are marketed to consumers interested in proactive health management, offering personalized insights based on bioactive data. Zivo's product portfolio spans from raw ingredients to finished test kits, all derived from its algal and bacterial host cultures. Zivo Bioscience's revenue streams are built around its proprietary algal strains, which serve as the foundation for all its products. The company's focus on natural compounds and bioactive molecules allows it to target both the supplement and medical food sectors, as well as the emerging market for personalized health diagnostics. By leveraging its research capabilities, Zivo provides specialized ingredients and diagnostic tools that cater to specific health challenges, particularly those related to immune response and inflammation. The firm's business model centers on creating value through scientific innovation in natural product development and health monitoring technologies. Zivo Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zivo Bioscience stock

EV/FCF (Enterprise Value to Free Cash Flow) of Zivo Bioscience is -12.30 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Zivo Bioscience changed from -8.94 to -12.30, representing a 37.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Zivo Bioscience since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Zivo Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Zivo Bioscience

All Key Metrics — Zivo Bioscience